Efficacy of curettage and co2 laser in treatment of basal cell carcinoma

Treatment of basal cell carcinoma with curettage co2 laser

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201105076403N1

Enrollment

113

Registered

2011-08-29

Start date

2006-07-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

basal cell carcinoma. Malignant neoplasms

Interventions

Use of combination of curettage and 2-3 pass of co2 laser with 16-20 watt and 500-700 microsecond.

Treatment - Devices

Use of combination of curettage and 2-3 pass of co2 laser with 16-20 watt and 500-700 microsecond

Eligibility

Sex/Gender

All

Age

20 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Pathologically documented basal cell carcinoma Exclusion criteria: basal cell carcinoma with deep ulcer, recurrent basal cell carcinoma, metastasis, association with bleeding diathesis, underlying repair disorder

Exclusion criteria

Exclusion criteria:

Design outcomes

Secondary

Measure	Time frame
Scar. Timepoint: At the end of the first, second, fourth week and every 3 month thereafter. Method of measurement: clinical observation.	—

Primary

Measure	Time frame
Treatment. Timepoint: At the end of the first, second, fourth week and every 3 month thereafter. Method of measurement: Clinical observation.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026